Max Healthcare Q4FY26 consolidated PAT grew 7% YoY, and revenue increased 12%. Network EBITDA rose 8%. Max Lab and Max@Home saw strong double-digit growth. The company also recommended a final dividend of Rs 2 per equity share for the year.